INOVIO PHARMACEUTICALS, INC. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- INOVIO PHARMACEUTICALS, INC. stock issued during period, shares, new issues for the quarter ending 2016-12-31 was 90.50K shares.
- INOVIO PHARMACEUTICALS, INC. stock issued during period, shares, new issues for the quarter ending 2016-09-30 was 448.85K shares.
- INOVIO PHARMACEUTICALS, INC. stock issued during period, shares, new issues for the quarter ending 2016-06-30 was 119.40K shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2016-12-31 | 90.50K shares derived: 10-Q 12 month − 10-Q 9 month · filed 2017-05-10 | 658.75K shares 10-Q · filed 2017-05-10 |
| 2016-09-30 | 448.85K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | |
| 2016-06-30 | 119.40K shares 10-Q · filed 2016-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |